Drug discovery

Clinical research
#Biomedical research #Drug discovery #Drug repurposing #LifeArc #Medical Research Council #Medicines repurposing

Toolkit launched for medicines repurposing

A free online toolkit has been launched to help researchers navigate the opportunities and challenges of repurposing medicines for different indications. The toolkit was created by medical research charity LifeArc and the Medical Research Council (MRC). “Having learned the challenges of repurposing firsthand, I think this toolkit is enormously practical… Read More

#News

#cryo-microscopy #Drug discovery #Proteins #Webinar

Webinar: Impact of cryo-EM on high resolution structure biology

Don’t miss the opportunity to register for this exclusive DDW event High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific. The webinar will take place on 19 October, 2022, 4PM BST, 8AM PDT. Discover how cryo-EM is impacting high… Read More

#News

Woman doing clinical research
#Computational chemistry #Drug discovery #Drug repurposing #Idiopathic pulmonary fibrosis #Lung disease #Medicines repurposing #Preclinical investigations

Cancer drug shows promise in treating incurable lung disease 

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).   Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical models of IPF according to the study published in the American Journal of… Read More

#News

#AI / data analytics / healthtech / informatics #Data automation #Data management #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Informatics

FAIR Game: making data work harder in the race to market 

Listen to this article on the DDW podcast: By Dr Christof Gänzler, Product Marketing Biology at PerkinElmer Informatics.  It’s a centuries-old truism: the fastest runner doesn’t always win the race. It takes more than speed to advance and maintain performance. It takes the right skill… Read More

#News

Child with cystic fibrosis on ventilator
#Antimicrobial resistance (AMR) #Cystic fibrosis #Drug discovery

Partnership seeks to transform Cystic Fibrosis research

LifeArc, a national medical research charity, is joining the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate in a strategic partnership alongside Cystic Fibrosis Trust and Medicines Discovery Catapult (MDC). The CF AMR Syndicate aims to address unmet patient needs by linking people with CF with leading experts across industry, academia… Read More

#News

#cryo-microscopy #Drug discovery #Webinar

Utilising novel sample preparation techniques to enhance Cryo-EM structural analysis 

Cryo-EM has been adopted into drug discovery workflows by the pharmaceutical and biotechnology industries having proved itself capable of delivering atomic resolution structures for key targets, including integral membrane proteins such as GPCRs and ion channels.   More recently, significant improvements in throughput have seen use of the… Read More

Webinar date:
Brought to you by SPT LabTech
#Webinars

Molecules
#Drug discovery #Fragment-based drug discovery #Hit identification

Introduction into FBDD webinar: last chance to register

Don’t miss your chance to register for the free webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. The event will take place on Thursday, October 13 at 3PM BST, 4PM CET, 10AM EST, 7AM PDT. Attendees will learn:… Read More

#News

#cryo-microscopy #Drug discovery #Proteins #Webinar

High resolution electron cryo-microscopy: register now

Join DDW for a webinar that will demonstrate how cryo-EM is impacting high resolution structure biology from membrane proteins to diseases including Alzheimer’s disease and cancer therapeutics by showing high-resolution structures of these proteins bound to inhibitors.  The exclusive free event High resolution electron cryo-microscopy: From… Read More

#News

#Cancer research #Cancer Research Horizons #Cancer Research UK #Drug development #Drug discovery #Oncology

New horizon for cancer innovation

Listen to this article on the DDW podcast: Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. Reece Armstrong sits down with Cancer Research Horizons’ Chief Business Officer,… Read More

#Cancer Research #Exclusive Content

Jigsaw puzzle of the brain
#Alzheimer's #Antibody #Clinical trial #Cognitive impairment #Drug development #Drug discovery #Phase III trial

New Alzheimer’s treatment reduces decline in Phase III trial

A new Alzheimer’s disease (AD) treatment has been shown to reduce clinical decline in mild cognitive impairment (MCI) due to AD and mild AD with confirmed presence of amyloid pathology in the brain.  Eisai and Biogen’s anti-amyloid beta (Aβ) protofibril antibody lecanemab met the primary endpoint and… Read More

#News

#Drug discovery #Fragment-based drug discovery #Hit identification

Understand the role of fragment-based drug discovery: webinar

Fragment-based drug discovery (FBDD) is one strategy used to identify novel and potent lead compounds.   Don’t miss out on this free webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. Fragments are small molecules with a low molecular weight (less than… Read More

#News

#Alzheimer's #Drug discovery #Inherited tauopathies #Neurodegenerative disorders #Neuroscience #Tau protein

Taking a new approach to tackle neurodegenerative diseases

Listen to this article on the DDW Podcast: William Erhardt, President, Head of Development & Operations of biotech Oligomerix, tells Lu Rahman about the company’s differentiated approach to developing disease-modifying therapeutics for neurodegenerative diseases.  New York-based Oligomerix is an emerging clinical-stage biotechnology company focused on… Read More

#Editor's Choice #Exclusive Content

Ice Bucket Challenge
#ALS #Drug discovery #FDA #Fundraising #Ice Bucket Challenge #The ALS Association

‘Ice Bucket Challenge’ funds FDA-approved ALS treatment

The US Food and Drug Administration (FDA) has granted approval to AMX0035, a new treatment for people living with amyotrophic lateral sclerosis (ALS). Development of the drug was funded by $2.2 million from the ALS Association, raised by the 2014 social media craze the ‘Ice Bucket Challenge’. Another… Read More

#News #Regulatory #Trending News

#Drug discovery #Microbiome #Synthetic biology

Stanford researchers construct the most complete synthetic microbiome

Listen to this article on the DDW Podcast: Rebecca McClellan, Scientific Program Manager, Research, Development & Communications, explains how scientists are learning more about the connections between the microbiome and human health to potentially develop first-in-class microbiome therapies. Key studies in the last decade have shown that the gut… Read More

#Exclusive Content